Secondary cataract inhibitor

Details Secondary cataract inhibitor Secondary cataract inhibitor

A - Human Necessities

61

K

A61K 31/195 (2006.01) A61K 31/196 (2006.01)

Patent

CA 2267320

A secondary cataract inhibitor containing as the active ingredient N-(3,4- dimethoxycinnamoyl)-anthranilic acid represented by formula (I) or pharmacologically acceptable salts thereof: efficacious in inhibiting, for example, posterior capsular turbidity after cataractal operation and useful for preventing or curing secondary cataract.

L'invention a trait à un inhibiteur de la cataracte secondaire contenant, comme ingrédient actif, un acide anthrenilique N-(3,4-diméthoxycinnamoyl), représenté par la formule (I), ou bien des sels de celui-ci acceptables du point de vue pharmacologique. Cet inhibiteur, qui s'avère efficace pour faire obstacle, notamment, à une turbidité capsulaire postérieure survenant après une opération de la cataracte, est également utile pour prévenir l'apparition d'une cataracte secondaire ou pour soigner celle-ci.

Affiliated with

Also associated with

Rating

Secondary cataract inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Secondary cataract inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Secondary cataract inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1802838